Herb Cross
CIK 1230721 · View on SEC EDGAR ↗
First SEC filing: Jan. 5, 2026 · Latest: Jan. 5, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | JSPRW | A | 90,000 | — | — | 90,000 Direct | — | Acquired | (price as of 2026-08-19) |
| June 4, 2025 | JSPRW | A | 90,000 | — | — | 90,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 13, 2025 | JSPRW | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Feb. 15, 2024 | JSPRW | A | 40,000 | — | — | 40,000 Direct | — | Acquired | (price as of 2026-08-19) |
| Sept. 22, 2023 | JSPRW | A | 550,000 | — | — | 550,000 Direct | — | Acquired | (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | JSPRW | Stock Option (right to buy) | Voting Common Stock (90,000) | $1.84 | Jan. 2, 2036 | 90,000 | Acquired |
| June 4, 2025 | JSPRW | Stock Option (right to buy) | Voting Common Stock (90,000) | $6.00 | June 4, 2035 | 90,000 | Acquired |
| Feb. 13, 2025 | JSPRW | Stock Option (right to buy) | Voting Common Stock (50,000) | $6.20 | Feb. 13, 2035 | 50,000 | Acquired |
| Feb. 15, 2024 | JSPRW | Stock Option (right to buy) | Voting Common Stock (40,000) | $17.95 | Feb. 15, 2034 | 40,000 | Acquired |
| Sept. 22, 2023 | JSPRW | Stock Option (right to buy) | Voting Common Stock (550,000) | $0.78 | Sept. 22, 2033 | 550,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $493,000 | — | — | $679,549 | $110,925 | — | — | $1,283,474 |
| 2024 | $476,100 | — | — | $612,732 | $182,108 | — | — | $1,270,940 |
| 2023 | $125,615 | $100,000 | — | $361,955 | $51,552 | — | $4,000 | $643,122 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.